☰

Brian J. Sworder, Ph.D. - Publications

Affiliations: 
2011 Boston University, Boston, MA, United States 
Area:
Cell Biology, Medicine and Surgery
Tree Info Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Hamilton MP, Craig E, Gentille Sanchez C, Mina A, Tamaresis J, Kirmani N, Ehlinger Z, Syal S, Good Z, Sworder B, Schroers-Martin J, Lu Y, Muffly L, Negrin RS, Arai S, et al. CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity. Blood Advances. PMID 38498731 DOI: 10.1182/bloodadvances.2024012637  0.303
2024 Kastenschmidt JM, Schroers-Martin JG, Sworder BJ, Sureshchandra S, Khodadoust MS, Liu CL, Olsen M, Kurtz DM, Diehn M, Wagar LE, Alizadeh AA. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment. Cell Stem Cell. 31: 410-420.e4. PMID 38402619 DOI: 10.1016/j.stem.2024.01.012  0.321
2022 Sworder BJ, Kurtz DM, Alig SK, Frank MJ, Shukla N, Garofalo A, Macaulay CWM, Shahrokh Esfahani M, Olsen MN, Hamilton J, Hosoya H, Hamilton M, Spiegel JY, Baird JH, Sugio T, et al. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. Cancer Cell. PMID 36584673 DOI: 10.1016/j.ccell.2022.12.005  0.305
2021 Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, Kurtz DM, Liu CL, Khameneh F, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles AJ, Newman AM, et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. PMID 34597589 DOI: 10.1016/j.ccell.2021.08.011  0.326
2020 Steen CB, Luca B, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Kurtz D, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Alizadeh A, Newman AM. Abstract 1557: Landscape of tumor cell states and cellular ecosystems in diffuse large B cell lymphoma Cancer Research. 80: 1557-1557. DOI: 10.1158/1538-7445.Am2020-1557  0.402
2019 Esfahani MS, Alig S, Kurtz DM, Soo J, Jin MC, Macaulay C, Craig AFM, Garofalo A, Steen CB, Scherer F, Sworder B, Diehn M, Alizadeh AA. Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling Blood. 134: 551-551. DOI: 10.1182/Blood-2019-132069  0.349
2019 Garofalo A, Schroers-Martin JG, Soo J, Kurtz DM, Sworder B, Liu CL, Pinsky BA, Luikart H, Advani RH, Natkunam Y, Khush K, Diehn M, Alizadeh AA. Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies Blood. 134: 885-885. DOI: 10.1182/Blood-2019-131602  0.361
2019 Macaulay C, Alig S, Kurtz DM, Jin MC, Opat S, Soo J, Sworder B, Hertzberg MS, Gandhi MK, Diehn M, Alizadeh AA. Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL Blood. 134: 1600-1600. DOI: 10.1182/Blood-2019-131278  0.385
2019 Wagar LE, Sworder B, Khodadoust MS, Davis MM, Alizadeh AA. Follicular Lymphoma Organoids for Investigating the Tumor Microenvironment Blood. 134: 2799-2799. DOI: 10.1182/Blood-2019-131192  0.403
2019 Steen CB, Luca BA, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Shamardani K, Kurtz DM, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Newman AM, et al. An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma Blood. 134: 655-655. DOI: 10.1182/Blood-2019-129461  0.453
2019 Alig S, Macaulay C, Kurtz DM, Dührsen U, Hüttmann A, Jin MC, Sworder B, Garofalo A, Esfahani MS, Soo J, Scherer F, Craig A, Casasnovas O, Westin JR, Gaidano G, et al. Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma Blood. 134: 491-491. DOI: 10.1182/Blood-2019-129283  0.416
2019 Sworder B, Kurtz DM, Macaulay C, Frank MJ, Alig S, Garofalo A, Sahaf B, Esfahani MS, Spiegel JY, Oak J, Beygi S, Jin MC, Chabon JJ, Khodadoust MS, Majzner RG, et al. Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy Blood. 134: 550-550. DOI: 10.1182/Blood-2019-129015  0.422
2018 Khodadoust MS, Olsson N, Chen B, Sworder B, Shree T, Liu CL, Zhang L, Czerwinski DK, Davis MM, Levy R, Elias JE, Alizadeh AA. B cell lymphomas present immunoglobulin neoantigens. Blood. PMID 30545830 DOI: 10.1182/Blood-2018-06-845156  0.337
2018 Jin MC, Schroers-Martin JG, Kurtz DM, Buedts L, Esfahani MS, Macaulay C, Sworder B, Soo J, Glover C, Roschewski M, Wilson WH, Dührsen U, Hüttmann A, Rossi D, Gaidano G, et al. Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma Blood. 132: 2838-2838. DOI: 10.1182/Blood-2018-99-119140  0.435
2015 Sissoko M, Sanchorawala V, Seldin D, Sworder B, Angelino K, Broce M, Berk J, Sloan JM. Clinical presentation and treatment responses in IgM-related AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-7. PMID 26488936 DOI: 10.3109/13506129.2015.1092433  0.396
2015 Sworder BJ, Yoshizawa S, Mishra PJ, Cherman N, Kuznetsov SA, Merlino G, Balakumaran A, Robey PG. Molecular profile of clonal strains of human skeletal stem/progenitor cells with different potencies. Stem Cell Research. 14: 297-306. PMID 25814434 DOI: 10.1016/J.Scr.2015.02.005  0.353
2015 Balakumaran A, Mishra PJ, Pawelczyk E, Yoshizawa S, Sworder BJ, Cherman N, Kuznetsov SA, Bianco P, Giri N, Savage SA, Merlino G, Dumitriu B, Dunbar CE, Young NS, Alter BP, et al. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders. Blood. 125: 793-802. PMID 25499762 DOI: 10.1182/Blood-2014-06-566810  0.363
2014 Sloan JM, Sissoko M, Seldin DC, Sworder B, Angelino K, Broce M, Berk JL, Sanchorawala V. Clinical Presentation and Treatment Responses in IgM AL Amyloidosis, a Series of 106 Patients Blood. 124: 4750-4750. DOI: 10.1182/Blood.V124.21.4750.4750  0.416
2013 Sanchorawala V, Seldin DC, Sworder B, Berk JL, Sloan JM. Clinical Presentation and Treatment Responses In IgM-Related AL Amyloidosis Blood. 122: 1991-1991. DOI: 10.1182/Blood.V122.21.1991.1991  0.407
2010 Balakumaran A, Pawelczyk E, Ren J, Sworder B, Chaudhry A, Sabatino M, Stroncek D, Frank JA, Robey PG. Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness". Plos One. 5: e11462. PMID 20628641 DOI: 10.1371/Journal.Pone.0011462  0.349
Show low-probability matches.